1-4 of 4
John H. Baird
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clinical features of neurotoxicity after CD19 CAR T-cell therapy in mantle cell lymphoma

Esther H. Nie, Yi-Jiun Su, John H. Baird, Neha Agarwal, Sushma Bharadwaj, Wen-Kai Weng, Melody Smith, Saurabh Dahiya, May H. Han, Jeffrey E. Dunn, Lucas B. Kipp, David B. Miklos, Brian J. Scott, Matthew J. Frank
Journal: Blood Advances
Blood Adv (2024) 8 (6): 1474–1486.
https://doi.org/10.1182/bloodadvances.2023011896
Published: 2024
Includes: Supplemental data
Journal Articles

Interferon-γ blockade in CAR T-cell therapy–associated macrophage activation syndrome/hemophagocytic lymphohistiocytosis

Clinical Trials & Observations
Michael Rainone, Dat Ngo, John H. Baird, L. Elizabeth Budde, Myo Htut, Ibrahim Aldoss, Vinod Pullarkat
Journal: Blood Advances
Blood Adv (2023) 7 (4): 533–536.
https://doi.org/10.1182/bloodadvances.2022008256
Published: 2023
Journal Articles

Immune reconstitution and infectious complications following axicabtagene ciloleucel therapy for large B-cell lymphoma

Clinical Trials & Observations
John H. Baird, David J. Epstein, John S. Tamaresis, Zachary Ehlinger, Jay Y. Spiegel, Juliana Craig, Gursharan K. Claire, Matthew J. Frank, Lori Muffly, Parveen Shiraz, Everett Meyer, Sally Arai, Janice (Wes) Brown, Laura Johnston, Robert Lowsky, Robert S. Negrin, Andrew R. Rezvani, Wen-Kai Weng, Theresa Latchford, Bita Sahaf, Crystal L. Mackall, David B. Miklos, Surbhi Sidana
Journal: Blood Advances
Blood Adv (2021) 5 (1): 143–155.
https://doi.org/10.1182/bloodadvances.2020002732
Published: 2021
Includes: Supplemental data
Journal Articles

A phase 2 study of brentuximab vedotin in patients with CD30-positive advanced systemic mastocytosis

Clinical Trials & Observations
Jason Gotlib, John H. Baird, Tracy I. George, Cheryl Langford, Isabel Reyes, Justin Abuel, Cecelia Perkins, Kurt Schroeder, Prithviraj Bose, Srdan Verstovsek
Journal: Blood Advances
Blood Adv (2019) 3 (15): 2264–2271.
https://doi.org/10.1182/bloodadvances.2019000152
Published: 2019
Includes: Supplemental data